Preclinical investigation in neuroprotective effects of the gpr55 Ligand VCE-006.1 in experimental models of Parkinson’s disease and amyotrophic lateral sclerosis

EDUARDO MUÑOZ BLANCO2026-01-292026-01-29202110.3390/molecules262476432-s2.0-85122178067https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/34260Analytical ChemistryChemistry (miscellaneous)Drug DiscoveryMolecular MedicineOrganic ChemistryPharmaceutical SciencePhysical and Theoretical ChemistryPreclinical investigation in neuroprotective effects of the gpr55 Ligand VCE-006.1 in experimental models of Parkinson’s disease and amyotrophic lateral sclerosisresearch article